Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury.

Fiebeler, A

Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury. [electronic resource] - Hypertension (Dallas, Tex. : 1979) Feb 2001 - 787-93 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1524-4563

10.1161/01.hyp.37.2.787 doi


Aldosterone--blood
Angiotensin II--genetics
Animals
Animals, Genetically Modified
Blood Pressure--drug effects
Body Weight
Cardiovascular Diseases--chemically induced
Fibroblast Growth Factor 2--genetics
Heart--drug effects
Immunohistochemistry
Mineralocorticoid Receptor Antagonists
NF-kappa B--metabolism
Organ Size
Platelet-Derived Growth Factor--metabolism
RNA, Messenger--metabolism
Rats
Receptors, Mineralocorticoid--physiology
Renin--genetics
Reverse Transcriptase Polymerase Chain Reaction
Spironolactone--pharmacology
Tetrazoles--pharmacology
Transcription Factor AP-1--metabolism
Transforming Growth Factor beta--metabolism
Valine--analogs & derivatives
Valsartan